Analysis of the Efficacy of Pemetrexed Maintenance Therapy in Patients with  Malignant Pleural Mesothelioma

Analysis of the Efficacy of Pemetrexed Maintenance Therapy in Patients with  Malignant Pleural Mesothelioma

Background and objective Malignant pleural mesothelioma (MPM) is a highly aggressive disease arising from pleural mesothelial cells. Advanced pleural mesothelioma has a poor prognosis, with a median survival of no more than 15 months. First line standard chemotherapy regimen recommended is Pemetrexe...

Full description

Bibliographic Details
Main Authors:	Xiaomei ZENG, Zhaoyou JIANG, Jianchun DUAN
Format:	Article
Language:	zho
Published:	Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2022-01-01
Series:	Chinese Journal of Lung Cancer
Subjects:	malignant pleural mesothelioma maintenance therapy pemetrexed progression free survival
Online Access:	http://dx.doi.org/10.3779/j.issn.1009-3419.2021.101.48

Similar Items

Systemic treatment in patients with malignant pleural mesothelioma – real life experience
by: Barbara Ziółkowska, et al.
Published: (2022-04-01)

Prognostic factors for progression‐free and overall survival in malignant pleural mesothelioma
by: Jordi Guzmán‐Casta, et al.
Published: (2021-04-01)

Four versus Six Cycles of Pemetrexed/Platinum as a First Line Treatment of Malignant Pleural Mesothelima: Results of a Randomized Phase II Study
by: Ahmed Nagy, et al.
Published: (2018-12-01)

Schedule-Dependent Treatment Increases Chemotherapy Efficacy in Malignant Pleural Mesothelioma
by: Darya Karatkevich, et al.
Published: (2022-10-01)

Malignant pleural mesothelioma with resolution of pleural effusion
by: Sayaka Nishida, et al.
Published: (2023-11-01)

Management of Pleural Effusion Secondary to Malignant Mesothelioma
by: Valeria Musso, et al.
Published: (2021-09-01)

In Vitro Characterization of Cisplatin and Pemetrexed Effects in Malignant Pleural Mesothelioma 3D Culture Phenotypes
by: Eleftherios D. Papazoglou, et al.
Published: (2019-09-01)

Excess of blood eosinophils prior to therapy correlates with worse prognosis in mesothelioma
by: Mégane Willems, et al.
Published: (2023-03-01)

Ancillary Diagnostic Investigations in Malignant Pleural Mesothelioma
by: Alex Dipper, et al.
Published: (2021-06-01)

Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study
by: Cova E, et al.
Published: (2019-01-01)

Interobserver Agreement in Histopathological Subtyping of Malignant Pleural Mesotheliomas
by: Mona MLIKA, et al.
Published: (2021-01-01)

Secondary Malignant Peritoneal Mesothelioma of the Greater Omentum after Therapy for Primary Pleural Mesothelioma
by: Andreas Gutzeit, et al.
Published: (2013-04-01)

Survival of Korean Patients with Malignant Pleural Mesothelioma Compensated for the Asbestos Injury Relief
by: Min-Sung Kang, et al.
Published: (2021-10-01)

Multimodal Treatment of Malignant Pleural Mesothelioma: Real-World Experience with 112 Patients
by: Arnulf Holzknecht, et al.
Published: (2022-04-01)

Pleural Fluid-to-Blood BNP Ratio May Contribute to Prognosis in Malignant Pleural Mesothelioma
by: Vasiliki Tsolaki, et al.
Published: (2023-09-01)

Clinical Analysis of 45 Patients with Malignant Pleural Mesothelioma
by: Jie CHEN, et al.
Published: (2012-02-01)

Malignant Pleural Mesothelioma: Spotlight on Recent Advances in Diagnosis and Treatment
by: Aline N. Zouk, et al.
Published: (2017-10-01)

The role of radiotherapy in the treatment of malignant pleural mesothelioma - possibilities and controversy
by: Arsenijević Tatjana, et al.
Published: (2024-01-01)

Diagnostic and Therapeutic Challenges of Malignant Pleural Mesothelioma
by: Jacopo Moro, et al.
Published: (2022-12-01)

Oncological Frontiers in the Treatment of Malignant Pleural Mesothelioma
by: Emanuele Vita, et al.
Published: (2021-05-01)

Job and environment factors in relation with pleural malignant mesothelioma and determination of occurrence chance of mesothelioma in exposure to asbestos
by: S. Mohammad Sadegh, et al.
Published: (2010-07-01)

Improvement of Malignant Pleural Mesothelioma Prognosis: Early Diagnosis and Multimodality Treatment
by: Cheng-Jun Ban, et al.
Published: (2017-01-01)

The Use of Chest Magnetic Resonance Imaging in Malignant Pleural Mesothelioma Diagnosis
by: Federica Volpi, et al.
Published: (2022-03-01)

Malignant pleural mesothelioma in a kidney transplant recipient
by: Wasinee Traipipitsiriwat, et al.
Published: (2021-04-01)

Advances in diagnosis and treatment of malignant pleural mesothelioma
by: Giorgio Vittorio Scagliotti, et al.
Published: (2011-12-01)

Advances in diagnosis and treatment of malignant pleural mesothelioma
by: Giorgio Vittorio Scagliotti, et al.
Published: (2011-12-01)

Calcitriol Inhibits Viability and Proliferation in Human Malignant Pleural Mesothelioma Cells
by: Iacopo Gesmundo, et al.
Published: (2020-10-01)

Circulating biomarkers in malignant pleural mesothelioma
by: Giuseppe Viscardi, et al.
Published: (2020-12-01)

An Autopsied Case of Malignant Sarcomatoid Pleural Mesothelioma in Which Chest Pain Developed Several Months Earlier without Abnormality on Imaging
by: Daizo Yaguchi, et al.
Published: (2015-10-01)

Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma
by: Qian Wang, et al.
Published: (2023-09-01)

The Evolving Role of Immune-Checkpoint Inhibitors in Malignant Pleural Mesothelioma
by: Maxime Borgeaud, et al.
Published: (2023-02-01)

Efficacy and toxicity profile of maintenance pemetrexed in patients with stage IV adenocarcinoma lung in Indian population
by: Goyal Pankaj, et al.
Published: (2016-01-01)

Malignant pleural mesothelioma
by: Rao Sukhesh
Published: (2009-01-01)

Current State-of-the-Art Therapy for Malignant Pleural Mesothelioma and Future Options Centered on Immunotherapy
by: Susana Cedres, et al.
Published: (2023-12-01)

Marital status as an independent prognostic factor for patients of malignant pleural mesothelioma
by: Shu Pan, et al.
Published: (2022-10-01)

Asbestos Exposure and Malignant Pleural Mesothelioma: A Systematic Review of Literature
by: Cátia Santos, et al.
Published: (2023-01-01)

Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience
by: Francesco Falanga, et al.
Published: (2022-10-01)

Induction Chemotherapy Followed by Pleurectomy Decortication and Hyperthermic Intraoperative Chemotherapy (HITHOC) for Early-Stage Epitheliod Malignant Pleural Mesothelioma—A Prospective Report
by: Stefano Bongiolatti, et al.
Published: (2021-11-01)

Correlation between pleural fluid cytology and magnitude of pleural invasion in patients with malignant pleural mesothelioma
by: Amr M. Shoukri, et al.
Published: (2016-11-01)

Association of <i>RERG</i> Expression with Female Survival Advantage in Malignant Pleural Mesothelioma
by: Assunta De Rienzo, et al.
Published: (2021-02-01)